MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    The cortical thickness signature and future phenoconversion in isolated REM-sleep behavior disorder: a longitudinal analysis

    JH. Shin, JY. Lee, HJ. Kim, YK. Kim, EJ. Yoon, HW. Nam, B. Jeon (Seoul, Republic of Korea)

    Objective: To develop an imaging biomarker predicting subtype-specific phenoconversion in isolated REM sleep behavior disorder (iRBD), we aim at identifying MRI-driven cortical thickness signature in…
  • 2022 International Congress

    NODDI- based maps as potential marker for Parkinson’s Disease.

    AP. Prabhu, S. Bhardwaj, A. Indoria, M. Gothwal, R. Yadav, PK. Pal, J. Saini (Bengaluru, India)

    Objective: To assess the predictive power of Diffusion Kurtosis Imaging (DKI) parameters obtained from Neurite orientation dispersion and density imaging tool (NODDI) to differentiate between…
  • 2022 International Congress

    Impact of foslevodopa/foscarbidopa on key clinical and patient-reported outcomes in patients with aPD: Responder analysis of two Phase 3 clinical trials

    M. Soileau, J. Aldred, A. Antonini, C. Carroll, V. Fung, T. Henriksen, R. Pahwa, D. Santos Garcia, A. Epstein, C. Yan, A. Alobaidi, A. Shewale, A. Spiegel, M. Facheris, J. Zamudio, P. Kukreja, KR. Chaudhuri (Georgetown, USA)

    Objective: To evaluate the effect of foslevodopa/foscarbidopa (LDP/CDP, ABBV-951) on clinical and patient-reported outcomes in advanced Parkinson’s disease (aPD) patients using minimal clinically important difference…
  • 2022 International Congress

    Intrafamilial phenotypic variability of spastic paraplegia type 7: A Case Report

    D. Shah-Zamora, M. Rosenbaum (Chicago, USA)

    Objective: To characterize the phenotypic variability of spastic paraplegia type 7 in a single family. Background: Spastic paraplegia type 7 (SPG7) is an autosomal recessive…
  • 2022 International Congress

    Efficacy And Safety Of Unilateral MRgFUS Thalamotomy In Patients With Essential Tremor

    V. Sharma, K. Lyons, L. O'Brien, K. Au, J. Cheng, M. Kinsman, R. Pahwa (Kansas City, USA)

    Objective: To report a single-institution experience of MRI guided high intensity focused ultrasound (MRgFUS) unilateral ventral intermediate nucleus (VIM) thalamotomy in patients with Essential tremor…
  • 2022 International Congress

    Cognitive profiling in a cohort of Huntington’s disease (HD) patients

    M. Garon, F. Pistonesi, L. Weis, V. Cianci, T. Gandolfi, E. Fiorenzato, C. Tedesco, M. Campagnolo, M. Carecchio, A. Antonini, R. Biundo (Padua, Italy)

    Objective: To define neuropsychological profile of HD patients adopting Parkinson’s disease Level II criteria for cognitive diagnosis[1]. Background: HD is a rare autosomal dominant genetic…
  • 2022 International Congress

    Video-oculographic biomarkers for evaluating vertical ocular dysfunction in progressive supranuclear palsy

    A. Quattrone, M. Crasà, M. Morelli, B. Vescio, A. Augimeri, V. Gramigna, A. Quattrone (Catanzaro, Italy)

    Objective: Objective: PSP patients typically show reduced amplitude and velocity of vertical saccades, but saccadic abnormalities have also been reported in PD. We investigated the…
  • 2022 International Congress

    Case report: Parkinsonim with dyskinesia secondary to amyloid angiopathy

    K. Khelfaoui Tredano, G. Berrada, Y. Hsaini, A. Benomar, H. Tibar (Rabat, Morocco)

    Objective: To report a case of parkinsonism secondary to amyloid angiopathy and discuss the pathophysiology and treatment of this entity. Background: Cerebral amyloid angiopathy is…
  • 2022 International Congress

    Comparison of Voice, Speech, Swallowing and Drooling Problems in Parkinson’s Disease Patients with Healthy Individuals

    M. Sapmaz Atalar, G. Genç, ş. Oğur (Istanbul, Turkey)

    Objective: To compare voice, speech, swallowing and drooling problems in Parkinson's disease (PD) patients with healthy individuals (HI) by using objective and subjective methods and…
  • 2022 International Congress

    Feasibility Of An Intensive Inpatient Parkinson’s Rehabilitation Program For Moderately Advanced Parkinson’s Disease

    L. Rubin, M. Mccrossin, C. Claro, A. Persaud, A. Hernandez, D. Barreto, K. Schlosser, E. Stack, P. Fischetti, J. Yu, D. Green, L. Ptarcinski, K. Greco, G. Fequiere, C. Francavilla, P. Moondra, A. Di Rocco (Glen Cove, USA)

    Objective: To determine the feasibility in the US of a multimodal intensive inpatient Parkinson’s Rehabilitation program for patients with moderately advanced Parkinson’s disease (PD) Background:…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley